China: A new wave of regulatory enforcement actions in China impact the food and pharmaceutical industries

Life Sciences Spotlight (Asia Pacific)
Last Updated: 10 September 2013
Article by Sammy Fang


A new leadership heralds change

China is currently witnessing an extended government campaign to tackle corruption on an unprecedented scale. The change in the Communist Party's leadership that began at the end of last year coincided with the arrest and indictment of the former Chongqing Party Secretary, Bo Xilai (the most senior official charged with corruption in recent memory). The wave of enforcement actions against corrupt officials that followed Bo's arrest has continued, recently leading to the head of the once powerful Ministry of Railways being sentenced to death for corruption. He is the most powerful former government official sentenced for corruption since President Xi Jinping became China's leader in March this year.

Recent regulatory and investigative action in China

However, the government's focus does not appear to be limited to public officials alone. In recent months, there have been a spate of regulatory and investigative enforcement actions by Chinese government authorities against companies in the private sector (including both multi-national companies and local Chinese companies), which are likely to have a major impact on the Life Sciences sector in China in the near and medium terms. These include:

  1. New regulations issued by the State Council which came into effect in May 2013 now impose tougher market entry requirements on infant formula manufacturers, including among others, requiring them to own their own milk sources, forbidding them to outsource production or use several brand names for the same infant formula. This has already led to a number of dairies being acquired by Chinese infant formula rands.
  2. China's anti-trust regulator, the National Development and Reform Commission (NDRC), announced in early July 2013 that it is investigating 33 Chinese domestic pharmaceutical companies and 27 international pharmaceutical companies operating in China (or their Chinese agents) with respect to the production costs of some of their products. The implication here is that similar to the NDRC's earlier investigation into the price of infant milk formula products, the NRDC considers the price of these pharmaceutical products are too high and are causing a financial burden on the public health insurance scheme.
  3. Reports of recent anti-bribery investigations against a number of international players in the pharmaceuticals industry led by the Chinese police, the Public Security Bureau (PSB), as well as the Administration of Industry and Commerce (AIC).

What it will mean for Life
Science sector players and multinationals operating in China?

In the past, government anti-bribery enforcement actions would target principally those government officials involved, rather than the companies that actually paid the bribes to these officials. The breadth of the latest investigations and regulatory intervention is, however, unprecedented, particularly as they involve so many government authorities and agencies (NDRC, PSB, and the AIC) who appear to be taking enforcement action concurrently. There has been no shortage of rumours coming out of the Chinese market in recent months as to how many foreign companies have been targeted by the government and the reasons that led to these investigations.

However, as modern socialist China enters into its fourth decade of economic development, there are complex and intertwined social, political and economic factors that are now driving this regulatory enforcement action by the government. With the public's interest on food safety and healthcare at an all-time high and the public becoming more willing to criticise corrupt behaviour, China's new leadership appears to be more willing to increase regulatory oversight on various high priority industries such as food, healthcare, real estate and construction, and telecommunications.

Eager to prove itself to the Chinese public and to establish a strong mandate to govern, greater regulation and stronger enforcement action is likely to continue into the second half of the new leadership's first five-year term in office (ending in 2017). This is likely to mean that practices that traditionally have been viewed as grey areas will be targeted and ultimately punished.

From a regulatory and compliance perspective, companies with a robust regulatory and compliance program and effective crisis management protocols will be in a strong position to respond to such government enforcement action, hopefully with as little potential negative impact on their business as possible. This should not be limited to a program that only responds to compliance issues as they arise. International companies operating in China will need to localise and update their approach to regulatory affairs and compliance, so that preventative measures are put in place across their entire business cycle covering:

  • how market access efforts are managed (such as engagement of consultants to assist with product registration);
  • review of sales and marketing practices (how these are monitored and audited for potential compliance breaches);
  • interactions with government officials and State-owned enterprises;
  • whether present compliance training materials and efforts are sufficient; and
  • protocols for responding to government enforcement action and investigations (how a company should respond to a PSB or AIC investigation and what its standard operating procedures are in case of a raid on its business premises).

© DLA Piper

This publication is intended as a general overview and discussion of the subjects dealt with. It is not intended to be, and should not used as, a substitute for taking legal advice in any specific situation. DLA Piper Australia will accept no responsibility for any actions taken or not taken on the basis of this publication.

DLA Piper Australia is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. For further information, please refer to

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions